Ardent Health Partners, LLCARDTNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +19.33% | +4.04% | +11.85% | +8.75% | -0.08% |
| Gross Profit Growth | +27.33% | +4.83% | +13.46% | -24.89% | +178.88% |
| EBITDA Growth | +214.35% | +12.05% | +28.81% | -48.73% | -25.40% |
| Operating Income Growth | +95.95% | -11.52% | +0.00% | +261.37% | -139.52% |
| Net Income Growth | +0.00% | +53.00% | +70.56% | -189.20% | -60.64% |
| EPS Growth | +0.00% | +57.89% | +73.33% | -189.47% | -60.00% |
| EPS Diluted Growth | +0.00% | +52.63% | +73.33% | -189.47% | -62.79% |
| Weighted Average Shares Growth | +0.45% | -2.23% | -1.78% | +2.52% | -1.39% |
| Weighted Average Shares Diluted Growth | -6.59% | -1.79% | -1.16% | +2.69% | +6.56% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +77.14% | +0.00% | -0.43% | +64.73% | +85.52% |
| Free Cash Flow Growth | +281.04% | +0.00% | -9.83% | +91.02% | +259.91% |
| Receivables Growth | -5.44% | +7.45% | +13.96% | -2.09% | -7.66% |
| Inventory Growth | +9.11% | +13.54% | +12.75% | +12.35% | +3.04% |
| Asset Growth | -2.87% | +6.93% | +9.08% | +7.38% | +6.74% |
| Book Value per Share Growth | +67.89% | +71.92% | +72.64% | +20.07% | +51.15% |
| Debt Growth | -4.77% | -2.90% | +0.80% | +1.03% | -0.78% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +6.86% | +5.91% | +7.98% | -33.67% | -49.69% |